Randomized Controlled Trial
Copyright ©The Author(s) 2019.
World J Clin Cases. Feb 26, 2019; 7(4): 452-465
Published online Feb 26, 2019. doi: 10.12998/wjcc.v7.i4.452
Figure 5
Figure 5 Patient acceptability of cleansing solution assessed by visual analog scale. A: Patient acceptability for palatability. Patient acceptability for palatability was significantly better in the 1.2 L PEG-ASC group than in the PEG-ELS group (5.7 cm ± 2.2 cm vs 5.0 cm ± 2.6 cm, P = 0.02); B: Patient acceptability for volume. Patient acceptability for volume was significantly better in the 1.2 L PEG-ASC group than in the PEG-ELS group (6.3 cm ± 2.1 cm vs 5.3 cm ± 2.5 cm, P = 0.03); C: Overall acceptability. Overall acceptability was significantly better in the 1.2 L PEG-ASC group than in the PEG-ELS group (7.70 cm ± 2.57 cm vs 5.80 cm ± 3.24 cm, P < 0.001). PEG-ASC: Polyethylene glycol plus ascorbic acid; PEG-ELS: Polyethylene glycol-based electrolyte solution; VAS: Visual analog scale.